TrialScientific reports2018

Evaluation of alpha-II-spectrin breakdown products as potential biomarkers for early recognition and severity of aneurysmal subarachnoid hemorrhage.

Linda Papa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.